Firms
Eventide Asset Management
- Founded
- —
- Type
- Venture capital
Funds0
No funds on record yet.
Team
No team members on record yet.
Co-investing
Bain Capital
Annexon Biosciences$100M · 2020-07-01
Kestra Medical Technologies$— · Unknown date
Annexon Biosciences$100M · Unknown date
AdvanCell$315M · Unknown date
Adage Capital Management
Ovid Therapeutics$60M · 2026-03-18
Annexon Biosciences$100M · 2020-07-01
Annexon Biosciences$100M · Unknown date
Ally Bridge Group
Ovid Therapeutics$60M · 2026-03-18
Ovid Therapeutics$80M · 2025-10-03
Blackstone Life Sciences
Annexon Biosciences$100M · 2020-07-01
Annexon Biosciences$100M · Unknown date
Janus Henderson Investors
Ovid Therapeutics$60M · 2026-03-18
Ovid Therapeutics$80M · 2025-10-03
Logos Capital
Annexon Biosciences$100M · 2020-07-01
Annexon Biosciences$100M · Unknown date
New Enterprise Associates
Annexon Biosciences$100M · 2020-07-01
Annexon Biosciences$100M · Unknown date
RA Capital Management
Ovid Therapeutics$60M · 2026-03-18
Ovid Therapeutics$80M · 2025-10-03
Sanofi Ventures
Sudo Biosciences$147M · 2023-12-20
AdvanCell$315M · Unknown date
T. Rowe Price
Kestra Medical Technologies$— · Unknown date
AdvanCell$315M · Unknown date
Alexandria Venture InvestmentsKaruna Therapeutics$82M · 2019-03-18
Alpha Wave Global
AdvanCell$315M · Unknown date
Andera Partners
Kestra Medical Technologies$— · Unknown date
ARCH Venture PartnersKaruna Therapeutics$82M · 2019-03-18
Catalio Capital Management
AdvanCell$315M · Unknown date
Cowen Healthcare Investments
Ovid Therapeutics$80M · 2025-10-03
Dementia Discovery Fund
Sudo Biosciences$147M · 2023-12-20
Enavate Sciences
Sudo Biosciences$147M · 2023-12-20
Fidelity Management & Research Company
Karuna Therapeutics$82M · 2019-03-18
Frazier Life Sciences
Sudo Biosciences$147M · 2023-12-20
Jeremy Levin
Ovid Therapeutics$80M · 2025-10-03
Leaps by Bayer
Sudo Biosciences$147M · 2023-12-20
Longitude Capital
Kestra Medical Technologies$— · Unknown date
Monograph Capital
Sudo Biosciences$147M · 2023-12-20
Omega Funds
Kestra Medical Technologies$— · Unknown date
Partner Fund Management
Karuna Therapeutics$82M · 2019-03-18
Pivotal bioVenture PartnersKaruna Therapeutics$82M · 2019-03-18
Point72 Asset Management
Ovid Therapeutics$60M · 2026-03-18
Sands CapitalKaruna Therapeutics$82M · 2019-03-18
Surveyor Capital
Sudo Biosciences$147M · 2023-12-20
TPG
Sudo Biosciences$147M · 2023-12-20
UPMC Enterprises
Sudo Biosciences$147M · 2023-12-20